Center for Biopharmaceuticals and Biobarriers in Drug Delivery

Oral drug delivery is generally considered the most convenient way of dosing drugs. It is most often both patient-friendly and cost-efficient. However, the drug must travel across many barriers in the body to reach its intended destination.

About the research

When a drug is taken orally, it can act locally in the oral cavity, stomach or intestines or may be absorbed into the body. For some drugs like biopharmaceuticals, however, the natural biological barriers of the stomach and intestines represent a huge barrier for uptake of the drug in sufficient amounts to be therapeutically relevant. Biopharmaceuticals comprise peptides and proteins for the treatment of life-threatening and debilitating diseases. Drug delivery systems for use in oral delivery of such peptides and proteins must, therefore, be specifically designed to aid the absorption of the drug, which represents a grand challenge

Project information

Principal Investigator (PI)

Improved drug delivery of these medications can result in better treatment of numerous serious diseases, e.g., cancer, diabetes or inflammatory diseases. Therefore, further research within the field of oral delivery of biopharmaceuticals will be undertaken to provide a new understanding of the impact of the interplay between the active drug molecule, the helper components, the design parameters, and the biological barriers. We will provide new insight on how this affects the interaction and transport of biopharmaceuticals in the body.

Our concept is to exploit the molecular properties of the components in the drug delivery systems (DDS) for improved delivery. We will elucidate and explain the mechanisms for interaction of both the biopharmaceutical(s), excipient(s), and the dosage form with mucus and epithelial membranes in biophysical and real-time transport studies.

Through an interdisciplinary research collaboration, we will combine long-standing experience in drug delivery and advanced formulation design with expertise in cutting-edge peptide and protein chemistry, nanobiophotonics, and advanced bioimaging. Specifically, we will chemically tailor structurally complicated drugs and excipients to control their properties at the nano-scale. We will design and synthesize new excipients that can be combined into novel, tailored drug delivery systems. We will use innovative light-driven microrobotics that can deposit nano-drug systems with unprecedented precision onto biological membranes. Finally, we will perform comprehensive in vivo bioimaging studies of the developed DDS.

Our vision is to establish a world-class center for oral drug delivery of biopharmaceuticals. We will study how to overcome biological barriers by formulation design through interdisciplinary research collaborations.

The mission is to provide an improved fundamental understanding of novel methods pursuing oral delivery of biopharmaceuticals through tailoring of drug delivery systems and advanced assessment tools.

Research Projects

Four key areas will be in focus as we work towards a new understanding as well as new methodology for oral delivery of biopharmaceuticals.

Each key area will be led by a leading expert within the field:

The research is organized in three work packages.

Chemical tailoring of biopharmaceuticals and excipients, design of drug delivery systems (DDS)

We will use functionalized biopharmaceuticals and excipient(s) and the biopharmaceuticals will be delivered in DDS via oral administration.

Main objectives and methodologies

  1. Design and chemical synthesis of novel excipients and systematically study their behavior and benchmark against conventional excipients. We address how excipients can be tailored to the specific biopharmaceutical
  2. Design and chemically synthesize biopharmaceuticals with modifications, which direct their physico-chemical properties, e.g., controlled self-assembly into oligomers or non-covalent binding to excipients
  3. Bioimaging labels will be conjugated to both biopharmaceutical and/or the excipient allowing tracking and imaging in in vitro and in vivo models.

Interaction with biomatrices and biobarriers

We will assemble biopharmaceuticals in drug delivery systems (DDS) by controlling molecular properties and formulation conditions in microfluidics and when needed include encapsulation in soft or solidified drug delivery systems.  

Main objectives and methodologies

  1. Obtain detailed insight at the molecular level on drug-excipient interactions, and thus the DDS properties in relevant biomatrices under relevant physiological conditions (e.g. enzymes, mucins and flow)
  2. Investigate mucus diffusion of the DDS
  3. Study in real-time (in contrast to traditional endpoint assays) the global and microdomain effects of DDS and excipient on epithelia surface and mucus
  4. Use emerging developments in lab-on-a-chip systems for in vitro epithelial models as well as microtools for exposure of the DDS at very specific locations on membranes.

In vivo dynamics and therapeutic potential

The ability to follow the fate of biopharmaceuticals at the cellular, tissue and whole-body level is crucial for the success of the center.

Main objectives and methodologies

  1. In vivo studies will be conducted to confirm and feed-back hypotheses derived from work package 1 and 2
  2. The dynamics and fate of biopharmaceuticals and drug delivery systems uptake from the intestine, and path after absorption will be investigated by live animal imaging. Furthermore, tissue samples will allow for higher resolution imaging.

Investigators

  • Ada-Ioana Bunea
    Assistant Professor
    • Job responsibility
      Polymer Micro & Nano Engineering, DTU Nanolab
  • Alexandre Emmanuel Wetzel
    Former Ph.D. Student
    • Job responsibility
      Polymer Micro & Nano Engineering, DTU Nanolab
  • Danai Anastasia Panou
    Former Ph.D Student
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Einstom Engay
    Postdoctoral Fellow
    • Job responsibility
      Polymer Micro & Nano Engineering, DTU Nanolab
  • Feng Wan
    Assistant Professor
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Gokce Endugar
    Ph.D., Postdoctoral Fellow
    • Job responsibility
      Faculty of Pharmaceutical Sciences, University of British Columbia
  • Hussein Chaaban
    Ph.D. Student
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Janni Støvring Mortensen
    Ph.D. Student
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Jannik Brøndsted Hovgaard
    Research Associate
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Jijo Vallooran Joy
    Assistant Professor
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Karina Juul Vissing
    Senior Laboratory Technician
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Kathy Saatchi
    Senior Research Associate
    • Job responsibility
      Faculty of Pharmaceutical Sciences, The University of British Columbia
  • Mai Bay Stie
    Ph.D. Student
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Marco van de Weert
    Associate Professor
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Marta Bergamo
    M.Sc., Ph.D Student
    • Job responsibility
      Faculty of Pharmaceutical Sciences, University of British Columbia
  • Mikkel Boas Thygesen
    Associate Professor
    • Job responsibility
      Department of Chemistry, University of Copenhagen
  • Narendra Kumar Mishra
    Postdoctoral Fellow
    • Job responsibility
      Department of Chemistry, University of Copenhagen
  • Niels Johan Christensen
    Postdoctoral Fellow
    • Job responsibility
      Department of Chemistry, University of Copenhagen
  • Nikos Hatzakis
    Associate Professor
    • Job responsibility
      Department of Chemistry, University of Copenhagen
  • Panagiota Kalomoiri
    Ph.D Student
    • Job responsibility
      Department of Chemistry, University of Copenhagen
  • Ragna Guldsmed Diedrichsen
    Ph.D. Student
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Stine Harloff-Helleberg
    Assistant Professor
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Sven Frøkjær
    Professor
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Sylvester Erik Gravesen Petersen
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Sylvia Natalie Klodzinska
    Postdoctoral Fellow
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Søren Schmidt-Rasmussen Nielsen
    Ph.D. Student
    • Job responsibility
      Department of Chemistry, University of Copenhagen
  • Tanya Saxena
    Ph.D. Student
    • Job responsibility
      Faculty of Pharmaceutical Sciences, The University of British Columbia
  • Vito Foderà
    Associate Professor
    • Job responsibility
      Department of Pharmacy, University of Copenhagen
  • Xin Zhou
    Former Ph.D. Student
    • Job responsibility
      Department of Pharmacy, University of Copenhagen

Principal Investigators (PI's)